DK0930885T3 - Anvendelsen af heparin eller heparansulfat kombineret med chitosan til forebyggelsen eller behandlingen af infektioner af herpesvirus - Google Patents

Anvendelsen af heparin eller heparansulfat kombineret med chitosan til forebyggelsen eller behandlingen af infektioner af herpesvirus

Info

Publication number
DK0930885T3
DK0930885T3 DK97934838T DK97934838T DK0930885T3 DK 0930885 T3 DK0930885 T3 DK 0930885T3 DK 97934838 T DK97934838 T DK 97934838T DK 97934838 T DK97934838 T DK 97934838T DK 0930885 T3 DK0930885 T3 DK 0930885T3
Authority
DK
Denmark
Prior art keywords
treatment
heparin
chitosan
prevention
combination
Prior art date
Application number
DK97934838T
Other languages
English (en)
Inventor
Olle Larm
Marcus Back
Tomas Bergstroem
Original Assignee
Medicarb Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medicarb Ab filed Critical Medicarb Ab
Application granted granted Critical
Publication of DK0930885T3 publication Critical patent/DK0930885T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
DK97934838T 1996-08-06 1997-08-01 Anvendelsen af heparin eller heparansulfat kombineret med chitosan til forebyggelsen eller behandlingen af infektioner af herpesvirus DK0930885T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9602931A SE507028C2 (sv) 1996-08-06 1996-08-06 Ny medicinsk användning
PCT/SE1997/001320 WO1998005341A1 (en) 1996-08-06 1997-08-01 The use of heparin or heparan sulphate in combination with chitosan for the prevention or treatment of infections caused by herpes virus

Publications (1)

Publication Number Publication Date
DK0930885T3 true DK0930885T3 (da) 2002-05-06

Family

ID=20403528

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97934838T DK0930885T3 (da) 1996-08-06 1997-08-01 Anvendelsen af heparin eller heparansulfat kombineret med chitosan til forebyggelsen eller behandlingen af infektioner af herpesvirus

Country Status (13)

Country Link
US (1) US6207653B1 (da)
EP (1) EP0930885B1 (da)
JP (1) JP2000515543A (da)
CN (1) CN1227493A (da)
AT (1) ATE215829T1 (da)
AU (1) AU705189B2 (da)
CA (1) CA2261742A1 (da)
DE (1) DE69711897T2 (da)
DK (1) DK0930885T3 (da)
ES (1) ES2174273T3 (da)
NZ (1) NZ333925A (da)
SE (1) SE507028C2 (da)
WO (1) WO1998005341A1 (da)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE508760C2 (sv) 1997-04-29 1998-11-02 Medicarb Ab Användning av en komposition innefattande kitosan i kombination med en polysackarid, som aktiv komponent i ett lösningsmedel, för framställning av ett spendoppningsmedel för mjölkproducerande djur
AU7070700A (en) * 1999-08-25 2001-03-19 Massachusetts Institute Of Technology Pharmaceutical preparations for the inhibition of herpes simplex virus 1 entry
US6977248B1 (en) * 1999-08-25 2005-12-20 Massachusetts Institute Of Technology Pharmaceutical preparations for the inhibition of herpes simplex virus 1 entry
SE9904289D0 (sv) * 1999-11-26 1999-11-26 Niklas Arnberg Method and camposition for the treatment of adenovairal ocular infections
US20020119949A1 (en) * 2001-02-26 2002-08-29 Asa Hellman Prophylactic teat treatment
US7968122B2 (en) * 2003-12-10 2011-06-28 Adventrx Pharmaceuticals, Inc. Anti-viral pharmaceutical compositions
EP1774971A1 (en) * 2005-10-14 2007-04-18 Advanced in Vitro Cell Technologies, S.L. Chitosan and heparin nanoparticles
KR101397386B1 (ko) * 2005-12-13 2014-05-26 엑스테라 메디컬 코퍼레이션 혈액으로부터 병원성 미생물, 염증 세포 또는 염증단백질의 체외 제거를 위한 방법
WO2008155683A1 (en) 2007-06-18 2008-12-24 Firmenich Sa Malodor counteracting compositions and method for their use
CL2008000156A1 (es) * 2008-01-18 2008-08-01 Igloo Zone Chile S A Gel estable hidrofilo en base a un polimero para aplicacion topica porque comprende quitosano disuelto en un solvente; proceso para obtener el gel para uso topico antes mencionado; uso del gel.
CN102458419A (zh) * 2009-06-10 2012-05-16 埃克塞拉医学有限责任公司 组合物用于治疗粘膜炎的用途
ES2861359T3 (es) 2009-12-01 2021-10-06 Exthera Medical Corp Dispositivo para eliminar citoquinas de la sangre con polisacáridos inmovilizados en superficie
US20110212181A1 (en) * 2010-02-26 2011-09-01 The University Of Hong Kong Compositions and methods for treating chronic respiratory inflammation
DK2557151T3 (da) * 2010-04-07 2017-12-11 Mitsubishi Gas Chemical Co S-adenosyl-L-methionin-holdig tørgærsammensætning med udmærket opbevaringsstabilitet og fremgangsmåde til fremstilling af samme
JPWO2011142484A1 (ja) * 2010-05-14 2013-07-22 株式会社日本触媒 ポリアルキレンイミンを含むウイルス感染症治療薬
WO2012112724A1 (en) 2011-02-15 2012-08-23 Exthera Medical, Llc Device and method for removal of blood-borne pathogens, toxins and inflammatory cytokines
EP2861273B1 (en) 2012-06-13 2017-08-23 ExThera Medical Corporation Use of heparin and carbohydrates to treat cancer
BR112015032134B1 (pt) 2013-06-24 2022-05-10 Exthera Medical Corporation Método de ligação em ponto de extremidade de uma manose não redutora a um substrato e esfera possuindo uma manose ligada em ponto de extremidade
BR112016009827B1 (pt) 2013-11-08 2021-10-26 Exthera Medical Corporation Método in vitro para concentrar patógenos infecciosos presentes em uma amostra biológica obtida a partir de um indivíduo sob suspeita de estar infectado com os ditos patógenos, concentrador e kit
EP3134146B1 (en) 2014-04-24 2024-12-25 ExThera Medical Corporation Method for removing bacteria from blood using high flow rate
US10857283B2 (en) 2014-09-22 2020-12-08 Exthera Medical Corporation Wearable hemoperfusion device
WO2017151797A1 (en) 2016-03-02 2017-09-08 Exthera Medical Corporation Method for treating drug intoxication
US11911551B2 (en) 2016-03-02 2024-02-27 Exthera Medical Corporation Method for treating drug intoxication
WO2020231830A1 (en) 2019-05-16 2020-11-19 Exthera Medical Corporation Method for modulating endothelial glycocalyx structure
EP4228595A1 (en) * 2020-10-14 2023-08-23 Medoderm GmbH Liquid composition for use in the prevention or reduction of skin irritation, allergy and/or an infectious disease
EP4401784A4 (en) * 2021-09-17 2025-09-10 Shawn Walker USE OF CHITOSAN COMPLEXES OR COMPOSITIONS TO REDUCE THE INFILTRATION OF ENVIRONMENTAL FACTORS INTO THE BRAIN

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU77562A1 (de) * 1977-06-17 1979-03-26 Ciba Geigy Ag Verfahren zur herstellung von neuen pharmazeutischen praeparaten
EP0240098A3 (en) 1986-04-04 1989-05-10 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Oligo and polysaccharides for the treatment of diseases caused by retroviruses
AU1052492A (en) 1991-01-31 1992-08-06 Farmitalia Carlo Erba S.R.L. Synergistic composition comprising a fibroblast growth factor and a sulfated polylsaccharide, for use as antiviral agent

Also Published As

Publication number Publication date
CN1227493A (zh) 1999-09-01
AU705189B2 (en) 1999-05-20
US6207653B1 (en) 2001-03-27
EP0930885B1 (en) 2002-04-10
WO1998005341A1 (en) 1998-02-12
DE69711897T2 (de) 2002-08-22
SE9602931D0 (sv) 1996-08-06
CA2261742A1 (en) 1998-02-12
NZ333925A (en) 2000-07-28
SE507028C2 (sv) 1998-03-16
DE69711897D1 (de) 2002-05-16
AU3791197A (en) 1998-02-25
SE9602931L (sv) 1998-02-07
EP0930885A1 (en) 1999-07-28
ATE215829T1 (de) 2002-04-15
JP2000515543A (ja) 2000-11-21
ES2174273T3 (es) 2002-11-01

Similar Documents

Publication Publication Date Title
DK0930885T3 (da) Anvendelsen af heparin eller heparansulfat kombineret med chitosan til forebyggelsen eller behandlingen af infektioner af herpesvirus
EE04605B1 (et) Taime ja surfaktanti sisaldav kompositsioon ning selle kasutamine lihtherpese viiruse ja teiste nakkushaiguste raviks ette nähtud ravimtoote valmistamiseks
BR9913406A (pt) Processo de tratamento de infecção causada por pelo menos um vìrus da famìlia flaviviridae e de doença associada com a citada infecção em um hospedeiro vivo possuindo a citada infecção
BR9913935A (pt) Métodos de tratamento e prevenção de infecção causada por pelo menos um vìrus da famìlia dos flaviviridae e doença associada com a dita infecção em um hospedeiro vivo
MXPA02012443A (es) Profarmaco en 3'' de 2'-desoxi-beta-l-nucleosidos.
AU1876095A (en) Use of 1-deoxynojirimycin and its derivatives for treating mammals infected with respiratory syncytial virus
EP0831873A4 (en) COMBINATORY THERAPY FOR THE TREATMENT OF HIV AND OTHER VIRAL INFECTIONS
FI904445A0 (fi) Antivirala foereningar.
EP1852121A3 (en) Lipid analogs for treating viral infections
EP0652011A4 (en) PROPHYLACTIC MEDICINE AND MEDICINAL PRODUCT FOR VIRAL DISEASES OF THE BREATHWAYS.
IL104780A0 (en) Sulfonic acid derivatives in the treatment of viral diseases
EP1670507A4 (en) VACCINE FOR THE TREATMENT AND PREVENTION OF HERPES SIMPLEX VIRUS INFECTION
EP0382551A3 (en) Prevention and treatment of herpes virus infections
BR9706938A (pt) Composto uso do mesmo formulação farmacêutica e processos para produzir o composto e para o tratamento ou a prevenção de sintomas ou efeitos de uma infecção virótica em um mamífero infectado incluindo um humano
BR9916043A (pt) Composto, uso do mesmo e de seus saisfarmaceuticamente aceitáveis, e, composiçãofarmacêutica para tratamento de infecções deherpes viral em pacientes
GB8926595D0 (en) Pharmaceutical compositions for use in the treatment herpes simplex virus infections
AU2880595A (en) Use of pharmaceutical agents for restoring, alleviation, or treatment of immunodeficiency, including the alleviation or treatment of the immune dysfunction related to infection with human immunodeficiency viruses (hiv) or related viruses
SE9303612D0 (sv) New use
ES2162862T3 (es) Uso de la timosina para tratar la hepatitis c en pacientes que no responden al tratamiento con interferon.
NO972688D0 (no) Anvendelse av aminopurin-antivirale-midler for behandling og profylakse av latente herpesvirus-infeksjoner
ATE295159T1 (de) Bupropion zur behandlung von viralen erkrankungen
BG100835A (bg) Ново лекарствено средство за лечение на вирусни инфекции на дихателните пътища
CA2082270A1 (en) Anti-viral therapy
WO2001013910A3 (en) Pharmaceutical preparations for the inhibition of herpes simplex virus 1 entry
IT1270008B (it) Derivati purinici ed 8-azapurinici atti al trattamento terapeutico dell'aids